Liptruzet Approved By FDA To Cut Cholesterol, Despite Criticism By Cardiologists
Liptruzet, a cholesterol-lowering drug that combines Merck’s Zetia (ezetimibe) with atorvastatin (generic version of Pfizer’s Lipitor) has been approved by
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓